Monograph: Corticosteroids General Statement

Corticosteroids General Statement

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Corticosteroids General Statement

ATC-Code

...

Classification

Introduction

Introduction

...

...

...

Uses

Uses

...

Adrenocortical Insufficiency

...

Adrenogenital Syndrome

...

Hypercalcemia

...

Thyroiditis

...

Rheumatic Disorders and Collagen Diseases

...

Dermatologic Diseases

...

Allergic Conditions

...

Ocular Disorders

...

Optic Neuritis

...

Other Ocular Disorders

...

Respiratory Diseases

...

Asthma

...

Considerations in Initiating Antiasthma Therapy

...

Mild Persistent Asthma

...

Moderate Persistent Asthma

...

Severe Persistent Asthma

...

Poorly Controlled Asthma

...

Home Management of Acute Asthma Exacerbations

...

Prehospital Management of Acute Asthma Exacerbations

...

Management of Acute Asthma Exacerbations in Acute-care Settings

...

Chronic Obstructive Pulmonary Disease

...

Sarcoidosis

...

Advanced Pulmonary and Extrapulmonary Tuberculosis

...

Advanced Pulmonary Tuberculosis

...

Tuberculous Meningitis

...

Tuberculous Pericarditis

...

Tuberculous Pleurisy

...

Other Tuberculosis Complications

...

Lipid Pneumonitis

...

Pneumocystis jirovecii Pneumonia

...

Coronavirus Disease 2019 (COVID-19)

...

Other Respiratory Diseases

...

Complications of Prematurity

...

Antenatal Use in Preterm Labor

...

Postnatal Use for Bronchopulmonary Dysplasia

...

Hematologic Disorders

...

GI Diseases

...

Crohn’s Disease

...

Trichinosis

...

Neoplastic Diseases

...

Cancer Chemotherapy-induced Nausea and Vomiting

...

Liver Diseases

...

Cerebral Edema

...

Head Injury

...

Cerebral Malaria

...

Acute Spinal Cord Injury

...

Low Back Pain

...

Bacterial Meningitis

...

Multiple Sclerosis

...

Myasthenia Gravis

...

Organ Transplants

...

Nephrotic Syndrome

...

Diagnostic Uses

...

Duchenne Muscular Dystrophy

...

Cardiovascular Disorders

...

Shock

...

Pericarditis

...

Chronic Fatigue Syndrome

...

Anthrax

...

Other Uses

...

...

Dosage and Administration

Dosage and Administration

...

Administration

...

Dosage

...

General Dosage

...

Table 1. Equivalent Oral Dosages of Glucocorticoids

...

Table 2. Equivalent Daily Dosages of Inhaled Glucocorticoids for Adults and Adolescents

...

Table 3. Equivalent Daily Dosages of Inhaled Glucocorticoids for Infants and Children

...

Coronavirus Disease 2019 (COVID-19)

...

Table 4. Equivalent IV or Oral Total Daily Dosages of Corticosteroidsa

...

Alternate-Day Therapy

...

Discontinuance of Therapy

...

...

Cautions

Cautions

...

Adrenocortical Insufficiency

...

Musculoskeletal Effects

...

Osteoporosis

...

Increased Susceptibility to Infection

...

Fluid and Electrolyte Disturbances

...

Ocular Effects

...

Endocrine Effects

...

GI Effects

...

Nervous System Effects

...

Dermatologic Effects

...

Other Adverse Effects

...

Precautions and Contraindications

...

Pediatric Precautions

...

Pregnancy and Lactation

...

Pregnancy

...

Lactation

...

...

Drug Interactions

Drug Interactions

...

Drugs Affecting Hepatic Microsomal Enzymes

...

Cyclosporine

...

Other Drugs

...

Antidiabetic Therapy

...

Estrogens

...

Nonsteroidal Anti-inflammatory Agents

...

Potassium-depleting Drugs

...

Vaccines and Toxoids

...

Oral Anticoagulants

...

...

Pharmacology

Pharmacology

...

Table 4. Duration of HPA-Axis Suppression After Single-Dose Oral Glucocorticoids

...

...

Pharmacokinetics

Pharmacokinetics

...

Absorption

...

Distribution

...

Elimination

...

...

Chemistry Section

Chemistry

...

...

Laboratory Test Interference

Laboratory Test Interferences

...

...

Common monograph Elements

Related Monographs

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2021, Selected Revisions August 30, 2021. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information